G250 peptide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for G250 peptide, covering 2013-09-05 to 2013-09-05. Get the full timeline:
Most recent: Clinical Trial Update: Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma [Phase 2]